MAPT and Alzheimer disease: SLAB51 boosted glucose absorption in 3xTg-AD mice by improving phosphorylated tau aggregates and memory function in the brain, and by restoring the expression levels of critical glucose transporters (GLUT3, GLUT1) and insulin-like growth factor receptor in the brain.